Correlation Between Roivant Sciences and Nautilus Biotechnology
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and Nautilus Biotechnology, you can compare the effects of market volatilities on Roivant Sciences and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Nautilus Biotechnology.
Diversification Opportunities for Roivant Sciences and Nautilus Biotechnology
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Roivant and Nautilus is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Nautilus Biotechnology go up and down completely randomly.
Pair Corralation between Roivant Sciences and Nautilus Biotechnology
If you would invest 268.00 in Roivant Sciences on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Roivant Sciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 1.56% |
| Values | Daily Returns |
Roivant Sciences vs. Nautilus Biotechnology
Performance |
| Timeline |
| Roivant Sciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nautilus Biotechnology |
Roivant Sciences and Nautilus Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Roivant Sciences and Nautilus Biotechnology
The main advantage of trading using opposite Roivant Sciences and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.| Roivant Sciences vs. Roivant Sciences | Roivant Sciences vs. Jasper Therapeutics | Roivant Sciences vs. Humacyte | Roivant Sciences vs. Reviva Pharmaceuticals Holdings |
| Nautilus Biotechnology vs. C4 Therapeutics | Nautilus Biotechnology vs. Kymera Therapeutics | Nautilus Biotechnology vs. Foghorn Therapeutics | Nautilus Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |